The American Association for the Study of Liver Diseases and the Latin American Association for the Study of the Liver will be presenting a joint webinar regarding Hepatitis C treatment simplification and management of special populations. This webinar will discuss the eligibility, recommended regimens, and on-treatment monitoring for simplified HCV treatment, review clinically important adverse effects, contraindications, and drug-drug interactions associate with medications used in the treatment of the hepatitis C virus, and describe the complications and management of hepatitis C virus infection in cancer patients, with a special focus on hepatocellular carcinoma. This webinar will be of interest to both English and Spanish speaking fellows/trainees, gastroenterologists, hepatologists, pharmacists, physician assistants, and other healthcare providers.

This webinar will be presented in Spanish.